Viking Therapeutics, Inc. (LON:0VQA)
London flag London · Delayed Price · Currency is GBP · Price in USD
38.67
+1.33 (3.55%)
At close: Aug 12, 2025

G1 Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
3,3163,5821,461598266301
Upgrade
Market Cap Growth
-53.03%145.09%144.27%125.11%-11.65%-31.25%
Upgrade
Enterprise Value
2,7192,8401,167471106114
Upgrade
Last Close Price
29.8531.8514.667.503.404.61
Upgrade
PB Ratio
5.715.095.344.961.781.68
Upgrade
P/TBV Ratio
5.715.095.344.961.781.68
Upgrade
Debt / Equity Ratio
0.000.000.000.0100.00
Upgrade
Quick Ratio
25.2632.9318.927.0923.0220.48
Upgrade
Current Ratio
25.8633.0919.197.6123.9821.12
Upgrade
Return on Equity (ROE)
-19.99%-17.90%-34.79%-39.67%-24.65%-15.15%
Upgrade
Return on Assets (ROA)
-14.99%-14.77%-23.47%-23.19%-14.90%-9.86%
Upgrade
Return on Capital (ROIC)
-15.48%-15.32%-25.38%-25.21%-15.58%-10.21%
Upgrade
Earnings Yield
-3.78%-2.45%-4.61%-9.55%-15.28%-9.62%
Upgrade
Buyback Yield / Dilution
-7.91%-15.57%-22.79%0.47%-6.34%-0.89%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.